2016 · The Journal of antimicrobial chemotherapy · paywalled
Mecillinam against genital Chlamydia trachomatis infection: a small-scale proof-of-concept study shows a low cure rate
Nilsen et al.
The finding, in our words
A small-scale trial of pivmecillinam for genital chlamydia was halted after only two of seventeen men who returned self-collected test-of-cure urine samples were cured. The low cure rate underscores the importance of follow-up sampling in decentralised STI management to verify treatment efficacy.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.